APA (7th ed.) Citation

Liu, J., Zhao, Q., Zhai, Y., Wu, X., Kai, J., Ruan, J., . . . Qiu, Y. (2024). Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: Results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects. Expert opinion on investigational drugs, 33(8), 867. https://doi.org/10.1080/13543784.2024.2377318

Chicago Style (17th ed.) Citation

Liu, Jian, et al. "Safety, Tolerability and Pharmacokinetics of ASC10, a Novel Oral Double Prodrug of a Broad-spectrum Antiviral Agent, β-d-N4-hydroxycytidine: Results from a Randomized, Double-blind, Placebo-controlled Phase 1 Study in Chinese Healthy Subjects." Expert Opinion on Investigational Drugs 33, no. 8 (2024): 867. https://doi.org/10.1080/13543784.2024.2377318.

MLA (9th ed.) Citation

Liu, Jian, et al. "Safety, Tolerability and Pharmacokinetics of ASC10, a Novel Oral Double Prodrug of a Broad-spectrum Antiviral Agent, β-d-N4-hydroxycytidine: Results from a Randomized, Double-blind, Placebo-controlled Phase 1 Study in Chinese Healthy Subjects." Expert Opinion on Investigational Drugs, vol. 33, no. 8, 2024, p. 867, https://doi.org/10.1080/13543784.2024.2377318.